Antifungal properties of the anti-hypertensive drug: Aliskiren

Abstract Objectives Aliskiren, the first in a new class of orally active renin inhibitors, is licensed for the treatment of hypertension. It inhibits plasma renin activity directly, thereby reducing generation of angiotensin II. In this study, we have explored the anti- Candida properties of aliskir...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of oral biology 2013-09, Vol.58 (9), p.1109-1115
Hauptverfasser: Kathwate, Gunderao Hanumantrao, Karuppayil, S. Mohan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1115
container_issue 9
container_start_page 1109
container_title Archives of oral biology
container_volume 58
creator Kathwate, Gunderao Hanumantrao
Karuppayil, S. Mohan
description Abstract Objectives Aliskiren, the first in a new class of orally active renin inhibitors, is licensed for the treatment of hypertension. It inhibits plasma renin activity directly, thereby reducing generation of angiotensin II. In this study, we have explored the anti- Candida properties of aliskiren. Methods Candida albicans was cultured in the presence or absence of aliskiren for various time periods. Subsequently, inhibition of growth, germtube formation, adhesion, early/matured biofilm development and secreted aspartic protease (SAP) activity were studied. Results When cultured in the presence of aliskiren, Candida showed significant reduction in the activity of aspartic proteases. Aliskiren impaired in vitro growth of C. albicans . It also affected two other virulence factors, germtube and adhesion. There is reduction in early and matured biofilm when treated with aliskiren. Conclusions Aliskiren could be considered as a candidate for antifungal drug development.
doi_str_mv 10.1016/j.archoralbio.2013.02.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1505349528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0003996913000642</els_id><sourcerecordid>1505349528</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-d2f8c6d9dc5a227d38bec5789a0d71b0e98bd2deeefa966578dc55b04327c79f3</originalsourceid><addsrcrecordid>eNqNkU1PxCAQhonRuOvHXzD15qUVaKHFg8lm41di4kE9EwpTl263XaHdZP-9NKvGeNETMPO-M8MzCJ0TnBBM-GWdKKcXnVNNabuEYpImmCYY8z00JUUuYsIw30dTjHEaC8HFBB15X4cn45wcoglNc0pxRqfoetb2thraN9VEa9etwfUWfNRVUb-ASIVkvNiOUWi93UBk3PB2Fc0a65fWQXuCDirVeDj9PI_R6-3Ny_w-fny6e5jPHmOdcdbHhlaF5kYYzRSluUmLEjTLC6GwyUmJQRSloQYAKiU4D5mgZCXOUprrXFTpMbrY1Q0zvg_ge7myXkPTqBa6wcvwYZZmgtHib2lGGBNFwUep2Em167x3UMm1syvltpJgOZKWtfxBWo6kJaYykA7es882Q7kC8-38QhsE850AApeNBSe9ttBqMAGc7qXp7L_aXP-qohvbWq2aJWzB193g2gBeEumDQT6PKx83TtJw42GMD4Ezqjc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1415598868</pqid></control><display><type>article</type><title>Antifungal properties of the anti-hypertensive drug: Aliskiren</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kathwate, Gunderao Hanumantrao ; Karuppayil, S. Mohan</creator><creatorcontrib>Kathwate, Gunderao Hanumantrao ; Karuppayil, S. Mohan</creatorcontrib><description>Abstract Objectives Aliskiren, the first in a new class of orally active renin inhibitors, is licensed for the treatment of hypertension. It inhibits plasma renin activity directly, thereby reducing generation of angiotensin II. In this study, we have explored the anti- Candida properties of aliskiren. Methods Candida albicans was cultured in the presence or absence of aliskiren for various time periods. Subsequently, inhibition of growth, germtube formation, adhesion, early/matured biofilm development and secreted aspartic protease (SAP) activity were studied. Results When cultured in the presence of aliskiren, Candida showed significant reduction in the activity of aspartic proteases. Aliskiren impaired in vitro growth of C. albicans . It also affected two other virulence factors, germtube and adhesion. There is reduction in early and matured biofilm when treated with aliskiren. Conclusions Aliskiren could be considered as a candidate for antifungal drug development.</description><identifier>ISSN: 0003-9969</identifier><identifier>EISSN: 1879-1506</identifier><identifier>DOI: 10.1016/j.archoralbio.2013.02.006</identifier><identifier>PMID: 23722042</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Advanced Basic Science ; Aliskiren ; Amides - chemistry ; Amides - pharmacology ; Antifungal Agents - pharmacology ; Antihypertensive Agents - pharmacology ; Aspartic Acid Proteases - secretion ; Biofilms - drug effects ; Candida albicans ; Candida albicans - drug effects ; Candida albicans - enzymology ; Candida albicans - growth &amp; development ; Cell Culture Techniques ; Dentistry ; Drug Repositioning ; Fumarates - chemistry ; Fumarates - pharmacology ; HIV protease inhibitors ; Microscopy, Electron, Scanning ; Renin - antagonists &amp; inhibitors ; Secreted aspartic proteases</subject><ispartof>Archives of oral biology, 2013-09, Vol.58 (9), p.1109-1115</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-d2f8c6d9dc5a227d38bec5789a0d71b0e98bd2deeefa966578dc55b04327c79f3</citedby><cites>FETCH-LOGICAL-c465t-d2f8c6d9dc5a227d38bec5789a0d71b0e98bd2deeefa966578dc55b04327c79f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.archoralbio.2013.02.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3541,27915,27916,45986</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23722042$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kathwate, Gunderao Hanumantrao</creatorcontrib><creatorcontrib>Karuppayil, S. Mohan</creatorcontrib><title>Antifungal properties of the anti-hypertensive drug: Aliskiren</title><title>Archives of oral biology</title><addtitle>Arch Oral Biol</addtitle><description>Abstract Objectives Aliskiren, the first in a new class of orally active renin inhibitors, is licensed for the treatment of hypertension. It inhibits plasma renin activity directly, thereby reducing generation of angiotensin II. In this study, we have explored the anti- Candida properties of aliskiren. Methods Candida albicans was cultured in the presence or absence of aliskiren for various time periods. Subsequently, inhibition of growth, germtube formation, adhesion, early/matured biofilm development and secreted aspartic protease (SAP) activity were studied. Results When cultured in the presence of aliskiren, Candida showed significant reduction in the activity of aspartic proteases. Aliskiren impaired in vitro growth of C. albicans . It also affected two other virulence factors, germtube and adhesion. There is reduction in early and matured biofilm when treated with aliskiren. Conclusions Aliskiren could be considered as a candidate for antifungal drug development.</description><subject>Advanced Basic Science</subject><subject>Aliskiren</subject><subject>Amides - chemistry</subject><subject>Amides - pharmacology</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antihypertensive Agents - pharmacology</subject><subject>Aspartic Acid Proteases - secretion</subject><subject>Biofilms - drug effects</subject><subject>Candida albicans</subject><subject>Candida albicans - drug effects</subject><subject>Candida albicans - enzymology</subject><subject>Candida albicans - growth &amp; development</subject><subject>Cell Culture Techniques</subject><subject>Dentistry</subject><subject>Drug Repositioning</subject><subject>Fumarates - chemistry</subject><subject>Fumarates - pharmacology</subject><subject>HIV protease inhibitors</subject><subject>Microscopy, Electron, Scanning</subject><subject>Renin - antagonists &amp; inhibitors</subject><subject>Secreted aspartic proteases</subject><issn>0003-9969</issn><issn>1879-1506</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1PxCAQhonRuOvHXzD15qUVaKHFg8lm41di4kE9EwpTl263XaHdZP-9NKvGeNETMPO-M8MzCJ0TnBBM-GWdKKcXnVNNabuEYpImmCYY8z00JUUuYsIw30dTjHEaC8HFBB15X4cn45wcoglNc0pxRqfoetb2thraN9VEa9etwfUWfNRVUb-ASIVkvNiOUWi93UBk3PB2Fc0a65fWQXuCDirVeDj9PI_R6-3Ny_w-fny6e5jPHmOdcdbHhlaF5kYYzRSluUmLEjTLC6GwyUmJQRSloQYAKiU4D5mgZCXOUprrXFTpMbrY1Q0zvg_ge7myXkPTqBa6wcvwYZZmgtHib2lGGBNFwUep2Em167x3UMm1syvltpJgOZKWtfxBWo6kJaYykA7es882Q7kC8-38QhsE850AApeNBSe9ttBqMAGc7qXp7L_aXP-qohvbWq2aJWzB193g2gBeEumDQT6PKx83TtJw42GMD4Ezqjc</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Kathwate, Gunderao Hanumantrao</creator><creator>Karuppayil, S. Mohan</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope></search><sort><creationdate>20130901</creationdate><title>Antifungal properties of the anti-hypertensive drug: Aliskiren</title><author>Kathwate, Gunderao Hanumantrao ; Karuppayil, S. Mohan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-d2f8c6d9dc5a227d38bec5789a0d71b0e98bd2deeefa966578dc55b04327c79f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Advanced Basic Science</topic><topic>Aliskiren</topic><topic>Amides - chemistry</topic><topic>Amides - pharmacology</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antihypertensive Agents - pharmacology</topic><topic>Aspartic Acid Proteases - secretion</topic><topic>Biofilms - drug effects</topic><topic>Candida albicans</topic><topic>Candida albicans - drug effects</topic><topic>Candida albicans - enzymology</topic><topic>Candida albicans - growth &amp; development</topic><topic>Cell Culture Techniques</topic><topic>Dentistry</topic><topic>Drug Repositioning</topic><topic>Fumarates - chemistry</topic><topic>Fumarates - pharmacology</topic><topic>HIV protease inhibitors</topic><topic>Microscopy, Electron, Scanning</topic><topic>Renin - antagonists &amp; inhibitors</topic><topic>Secreted aspartic proteases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kathwate, Gunderao Hanumantrao</creatorcontrib><creatorcontrib>Karuppayil, S. Mohan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Archives of oral biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kathwate, Gunderao Hanumantrao</au><au>Karuppayil, S. Mohan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antifungal properties of the anti-hypertensive drug: Aliskiren</atitle><jtitle>Archives of oral biology</jtitle><addtitle>Arch Oral Biol</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>58</volume><issue>9</issue><spage>1109</spage><epage>1115</epage><pages>1109-1115</pages><issn>0003-9969</issn><eissn>1879-1506</eissn><abstract>Abstract Objectives Aliskiren, the first in a new class of orally active renin inhibitors, is licensed for the treatment of hypertension. It inhibits plasma renin activity directly, thereby reducing generation of angiotensin II. In this study, we have explored the anti- Candida properties of aliskiren. Methods Candida albicans was cultured in the presence or absence of aliskiren for various time periods. Subsequently, inhibition of growth, germtube formation, adhesion, early/matured biofilm development and secreted aspartic protease (SAP) activity were studied. Results When cultured in the presence of aliskiren, Candida showed significant reduction in the activity of aspartic proteases. Aliskiren impaired in vitro growth of C. albicans . It also affected two other virulence factors, germtube and adhesion. There is reduction in early and matured biofilm when treated with aliskiren. Conclusions Aliskiren could be considered as a candidate for antifungal drug development.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>23722042</pmid><doi>10.1016/j.archoralbio.2013.02.006</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-9969
ispartof Archives of oral biology, 2013-09, Vol.58 (9), p.1109-1115
issn 0003-9969
1879-1506
language eng
recordid cdi_proquest_miscellaneous_1505349528
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Advanced Basic Science
Aliskiren
Amides - chemistry
Amides - pharmacology
Antifungal Agents - pharmacology
Antihypertensive Agents - pharmacology
Aspartic Acid Proteases - secretion
Biofilms - drug effects
Candida albicans
Candida albicans - drug effects
Candida albicans - enzymology
Candida albicans - growth & development
Cell Culture Techniques
Dentistry
Drug Repositioning
Fumarates - chemistry
Fumarates - pharmacology
HIV protease inhibitors
Microscopy, Electron, Scanning
Renin - antagonists & inhibitors
Secreted aspartic proteases
title Antifungal properties of the anti-hypertensive drug: Aliskiren
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T05%3A15%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antifungal%20properties%20of%20the%20anti-hypertensive%20drug:%20Aliskiren&rft.jtitle=Archives%20of%20oral%20biology&rft.au=Kathwate,%20Gunderao%20Hanumantrao&rft.date=2013-09-01&rft.volume=58&rft.issue=9&rft.spage=1109&rft.epage=1115&rft.pages=1109-1115&rft.issn=0003-9969&rft.eissn=1879-1506&rft_id=info:doi/10.1016/j.archoralbio.2013.02.006&rft_dat=%3Cproquest_cross%3E1505349528%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1415598868&rft_id=info:pmid/23722042&rft_els_id=S0003996913000642&rfr_iscdi=true